⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Table S1 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling

Christen A. Khella Lucyann Franciosa Lorna Rodrı́guez-Rodrı́guez Resha Rajkarnikar Karthikeyan Mythreye Michael L. Gatza

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Summary of the IHC staining of HCK in ovarian cancer tissue microarrays.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Khella et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db643587523915 https://doi.org/10.1158/1541-7786.27035140.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling2024
2Fig S2 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling2024
3Table S3 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling2024
4Table S3 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling2024
5Fig S4 from HCK promotes high-grade serous ovarian cancer tumorigenesis through CD44 and NOTCH3 signaling2024